TYRA Biosciences
NASDAQ: TYRACarlsbad, US · Incorporated in Delaware · 4 known investors
Biotechin /tyra-biosciences
Founders & leadership
RM
Robert MoreDirector
HT
Hiroomi Tada, M.D., Ph.D.Executive Officer
IC
Isan Chen, M.D.Director
DB
Daniel BensenExecutive Officer
NK
Nina KjellsonDirector
AF
Alan FuhrmanExecutive Officer
RV
Rehan VerjeeDirector
MM
Melissa McCracken, Ph.D.Director
SS
Sid Subramony, Ph.D.Director
GK
Gilla Kaplan, Ph.D.Director
JS
Jake Simson, Ph.D.Director
TH
Todd Harris, Ph.D.Executive Officer, Director
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$200MraisedFeb 2024 · 21 investors · BiotechnologyRule 506(b)
▶$200MraisedFeb 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert MoreDirector
- Hiroomi Tada, M.D., Ph.D.Executive Officer
- Isan Chen, M.D.Director
- Daniel BensenExecutive Officer
- Nina KjellsonDirector
- Alan FuhrmanExecutive Officer
- Rehan VerjeeDirector
- Melissa McCracken, Ph.D.Director
- Sid Subramony, Ph.D.Director
- Gilla Kaplan, Ph.D.Director
- Jake Simson, Ph.D.Director
- Todd Harris, Ph.D.Executive Officer, Director
- Offering amount
- $200M
- Amount sold
- $200M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.